BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32950597)

  • 1. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
    Liu M; Zhou R; Guo C; Xu R; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Liu F; Liu Y; Pan Y; Cai H; Weiss NS; He Z; Ke Y
    Gastrointest Endosc; 2021 May; 93(5):1065-1073.e3. PubMed ID: 32950597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
    Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
    Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Lugol-unstained lesions predict higher cumulative risk of malignance in the esophagus.
    Qi Z; Liu M; Zhou R; Guo C; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Wu N; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    J Gastroenterol Hepatol; 2023 Mar; 38(3):416-423. PubMed ID: 36418206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lugol-unstained lesions location in the esophagus affects the detection rate of malignancy: a population-based study.
    Qin J; Liu M; Liu A; Guo C; Qi Z; Zhou R; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2167-2173. PubMed ID: 37726891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
    Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
    Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
    Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should extra-large Lugol-unstained lesions of the esophagus be treated? Results from a population-based cohort study.
    Liu M; Qi Z; Zhou R; Guo C; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    Cancer Med; 2023 Oct; 12(19):20129-20139. PubMed ID: 37732496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China.
    Li J; Xu R; Liu M; Cai H; Cao C; Liu F; Li F; Guo C; Pan Y; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1585-1592. PubMed ID: 29174712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lugol's solution in endoscopic diagnosis of early esophageal cancer].
    Wang G; Zhou M; Cong Q
    Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):417-8, 446. PubMed ID: 7553162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHROMOENDOSCOPY USING TOLUIDINE BLUE PLUS LUGOL'S SOLUTION FOR EARLY DIAGNOSIS OF ESOPHAGEAL PREMALIGNANT LESIONS AND SUPERFICIAL NEOPLASMS IN HIGH-RISK PATIENTS.
    Piñerúa-Gonsálvez JF; Zambrano-Infantino RDC; Benítez S
    Arq Gastroenterol; 2019; 56(1):41-44. PubMed ID: 31141072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
    Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
    Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.
    Yoshikawa I; Yamasaki M; Yamasaki T; Kume K; Otsuki M
    Gastrointest Endosc; 2005 Nov; 62(5):698-703; quiz 752, 754. PubMed ID: 16246682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus.
    Kaneko K; Katagiri A; Konishi K; Kurahashi T; Ito H; Kumekawa Y; Yamamoto T; Muramoto T; Kubota Y; Nozawa H; Makino R; Kushima M; Imawari M
    Br J Cancer; 2007 Feb; 96(3):492-8. PubMed ID: 17285122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
    Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
    J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study.
    Mwachiro MM; Burgert SL; Lando J; Chepkwony R; Bett C; Bosire C; Abnet CC; Githanga J; Waweru W; Giffen CA; Murphy G; White RE; Topazian MD; Dawsey SM
    Am J Gastroenterol; 2016 Apr; 111(4):500-7. PubMed ID: 26902228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?
    Fagundes RB; Melo CR; Pütten AC; Moreira LF; de Barros SG
    Cancer Detect Prev; 2005; 29(3):227-32. PubMed ID: 15936591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of double vital staining with lugol's iodine and methylene blue in diagnosing superficial esophageal lesions.
    Peng G; Long Q; Wu Y; Zhao J; Chen L; Li X
    Scand J Gastroenterol; 2011 Apr; 46(4):406-13. PubMed ID: 21189106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil.
    Freitag CP; Barros SG; Kruel CD; Putten AC; Dietz J; Gruber AC; Diehl AS; Meurer L; Breyer HP; Wolff F; Vidal R; Arruda CA; Luz LP; Fagundes RB; Prolla JC
    Dis Esophagus; 1999; 12(3):191-5. PubMed ID: 10631911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fujinon intelligent color enhancement for the diagnosis of early esophageal squamous cell carcinoma and precancerous lesion.
    Li YX; Shen L; Yu HG; Luo HS; Yu JP
    Turk J Gastroenterol; 2014 Aug; 25(4):365-9. PubMed ID: 25254516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial.
    Protano MA; Xu H; Wang G; Polydorides AD; Dawsey SM; Cui J; Xue L; Zhang F; Quang T; Pierce MC; Shin D; Schwarz RA; Bhutani MS; Lee M; Parikh N; Hur C; Xu W; Moshier E; Godbold J; Mitcham J; Hudson C; Richards-Kortum RR; Anandasabapathy S
    Gastroenterology; 2015 Aug; 149(2):321-329. PubMed ID: 25980753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.